Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-05-21
1989-04-18
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548496, A61K 31405, C07D20920
Patent
active
048228125
ABSTRACT:
This invention relates to pharmacologically-active novel compounds comprising .beta.-fluoromethylene-5-hydroxytryptophan and derivatives, to methods of inhibiting monoamine oxidase and to treating depression, and to pharmaceutical compositions containing the compounds.
REFERENCES:
patent: 4029807 (1977-07-01), Roldau et al.
patent: 4421767 (1983-12-01), Palfreyman
patent: 4454158 (1984-06-01), Beg
Bioorg. Chem. 14, 103 (1986) Ian A. McDonald et al.
Collard Jean-Noel
McDonald Ian A.
Palfreyman Michael G.
Merrell Dow Pharmaceuticals Inc.
Springer David B.
Wille Louis J.
LandOfFree
.beta.-(Fluoromethylene)-5-hydroxytryptophan and derivatives and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-(Fluoromethylene)-5-hydroxytryptophan and derivatives and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-(Fluoromethylene)-5-hydroxytryptophan and derivatives and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397215